Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 7 studies | 36% ± 22% | |
macrophage | 5 studies | 22% ± 8% | |
GABAergic neuron | 5 studies | 40% ± 19% | |
gamma-delta T cell | 4 studies | 26% ± 6% | |
dendritic cell | 4 studies | 21% ± 7% | |
mast cell | 4 studies | 17% ± 2% | |
non-classical monocyte | 3 studies | 21% ± 6% | |
myeloid cell | 3 studies | 21% ± 2% | |
interneuron | 3 studies | 43% ± 17% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 35% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 2085.30 | 965 / 966 | 98% | 14.09 | 519 / 527 |
stomach | 100% | 2197.22 | 359 / 359 | 98% | 13.94 | 279 / 286 |
lung | 100% | 2988.40 | 578 / 578 | 97% | 15.21 | 1122 / 1155 |
pancreas | 100% | 1508.26 | 328 / 328 | 97% | 16.55 | 172 / 178 |
brain | 98% | 3275.61 | 2581 / 2642 | 98% | 17.69 | 693 / 705 |
breast | 100% | 2261.47 | 459 / 459 | 94% | 15.04 | 1050 / 1118 |
thymus | 100% | 2705.73 | 653 / 653 | 93% | 17.38 | 562 / 605 |
kidney | 99% | 1307.98 | 88 / 89 | 93% | 14.19 | 841 / 901 |
skin | 98% | 1447.21 | 1775 / 1809 | 93% | 11.15 | 439 / 472 |
bladder | 100% | 1821.57 | 21 / 21 | 88% | 9.74 | 445 / 504 |
uterus | 97% | 1988.97 | 165 / 170 | 87% | 9.83 | 401 / 459 |
esophagus | 89% | 1330.79 | 1290 / 1445 | 94% | 12.52 | 172 / 183 |
prostate | 100% | 2040.22 | 244 / 245 | 80% | 5.81 | 402 / 502 |
adrenal gland | 97% | 1225.38 | 251 / 258 | 53% | 4.87 | 122 / 230 |
ovary | 24% | 211.29 | 43 / 180 | 89% | 10.68 | 383 / 430 |
adipose | 100% | 2855.85 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1907.78 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.11 | 1 / 1 |
muscle | 100% | 2527.47 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1438.68 | 851 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1985.24 | 1316 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 11.22 | 78 / 80 |
tonsil | 0% | 0 | 0 / 0 | 91% | 8.63 | 41 / 45 |
lymph node | 0% | 0 | 0 / 0 | 90% | 9.00 | 26 / 29 |
peripheral blood | 83% | 1774.03 | 775 / 929 | 0% | 0 | 0 / 0 |
liver | 23% | 143.91 | 53 / 226 | 42% | 4.52 | 169 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
GO_0007165 | Biological process | signal transduction |
GO_0019933 | Biological process | cAMP-mediated signaling |
GO_0106070 | Biological process | regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0007608 | Biological process | sensory perception of smell |
GO_0010738 | Biological process | regulation of protein kinase A signaling |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0006198 | Biological process | cAMP catabolic process |
GO_0032587 | Cellular component | ruffle membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0030552 | Molecular function | cAMP binding |
GO_0047555 | Molecular function | 3',5'-cyclic-GMP phosphodiesterase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0004115 | Molecular function | 3',5'-cyclic-AMP phosphodiesterase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PDE4A |
Protein name | cAMP specific phosphodiesterase variant PDE4A-10 cAMP specific phosphodiesterase variant TM3 3',5'-cyclic-AMP phosphodiesterase 4A (EC 3.1.4.53) (DPDE2) (PDE46) (cAMP-specific phosphodiesterase 4A) 3',5'-cyclic-AMP phosphodiesterase (EC 3.1.4.53) |
Synonyms | DPDE2 |
Description | FUNCTION: Hydrolyzes the second messenger 3',5'-cyclic AMP (cAMP), which is a key regulator of many important physiological processes. .; FUNCTION: [Isoform 1]: Efficiently hydrolyzes cAMP. .; FUNCTION: [Isoform 2]: Efficiently hydrolyzes cAMP. .; FUNCTION: [Isoform 3]: Efficiently hydrolyzes cAMP. The phosphodiesterase activity is not affected by calcium, calmodulin or cyclic GMP (cGMP) levels. Does not hydrolyze cGMP. .; FUNCTION: [Isoform 4]: Efficiently hydrolyzes cAMP. .; FUNCTION: [Isoform 6]: Efficiently hydrolyzes cAMP. .; FUNCTION: [Isoform 7]: Efficiently hydrolyzes cAMP. . |
Accessions | ENST00000589073.1 ENST00000592685.5 [P27815-7] ENST00000293683.9 [P27815-2] ENST00000380702.7 [P27815-1] ENST00000440014.6 [P27815-6] P27815 K7ENX7 ENST00000591971.5 Q9HC30 K7EKV1 Q9HC31 ENST00000344979.7 [P27815-4] |